Ken Griffin Sutro Biopharma, Inc. Put Options Transaction History

Citadel Advisors LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$2.88 - $5.01 $21,312 - $37,074	7,400 Added 200.0%	11,100 $38,000
Q2 2024 Aug 14, 2024	BUY	$2.92 - $5.33 $3,796 - $6,929	1,300 Added 54.17%	3,700 $10,000
Q1 2024 May 15, 2024	BUY	$3.27 - $5.65 $4,251 - $7,345	1,300 Added 118.18%	2,400 $13,000
Q4 2022 Feb 14, 2023	BUY	$5.41 - $8.08 $5,951 - $8,888	1,100 New	1,100 $8,000

137

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $96.5M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.